Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms

01 Pubblicazione su rivista
Pascarelli M. T., Del Percio C., De Pandis M. F., Ferri R., Lizio R., Noce G., Lopez S., Rizzo M., Soricelli A., Nobili F., Arnaldi D., Fama F., Orzi F., Buttinelli C., Giubilei F., Salvetti M., Cipollini V., Franciotti R., Onofri M., Fuhr P., Gschwandtner U., Ransmayr G., Aarsland D., Parnetti L., Farotti L., Marizzoni M., D'Antonio F., De Lena C., Guntekin B., Hanoglu L., Yener G., Emek-Savas D. D., Ivano Triggiani A., Paul Taylor J., McKeith I., Stocchi F., Vacca L., Hampel H., Frisoni G. B., Bonanni L., Babiloni C.
ISSN: 1388-2457

Objective: Here we tested if cortical sources of resting state electroencephalographic (rsEEG) rhythms may differ in sub-groups of patients with prodromal and overt dementia with Lewy bodies (DLB) as a function of relevant clinical symptoms. Methods: We extracted clinical, demographic and rsEEG datasets in matched DLB patients (N = 60) and control Alzheimer's disease (AD, N = 60) and healthy elderly (Nold, N = 60) seniors from our international database. The eLORETA freeware was used to estimate cortical rsEEG sources. Results: As compared to the Nold group, the DLB and AD groups generally exhibited greater spatially distributed delta source activities (DLB > AD) and lower alpha source activities posteriorly (AD > DLB). As compared to the DLB “controls”, the DLB patients with (1) rapid eye movement (REM) sleep behavior disorders showed lower central alpha source activities (p < 0.005); (2) greater cognitive deficits exhibited higher parietal and central theta source activities as well as higher central, parietal, and occipital alpha source activities (p < 0.01); (3) visual hallucinations pointed to greater parietal delta source activities (p < 0.005). Conclusions: Relevant clinical features were associated with abnormalities in spatial and frequency features of rsEEG source activities in DLB patients. Significance: Those features may be used as neurophysiological surrogate endpoints of clinical symptoms in DLB patients in future cross-validation prospective studies.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma